Cyndeo Wealth Partners, LLC Novartis Ag Transaction History
Cyndeo Wealth Partners, LLC
- $1.27 Billion
- Q2 2024
A detailed history of Cyndeo Wealth Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cyndeo Wealth Partners, LLC holds 4,836 shares of NVS stock, worth $559,089. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,836
Previous 5,949
18.71%
Holding current value
$559,089
Previous $575,000
10.61%
% of portfolio
0.04%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.41 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$857 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$856 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$687 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...